Author

Camilla Shaw

Institution: Allakos (United States)

Observed institutions: Northwestern University, University of North Carolina at Chapel Hill, Mayo Clinic, Baylor College of Medicine, University of Utah, Allakos (United States), University of Pennsylvania, Icahn School of Medicine at Mount Sinai

OpenAlex ID: A5001543592

Anti–Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis

2020 · Evan S. Dellon, Kathryn A. Peterson, et al. · New England Journal of Medicine · 268

AK002, an Anti-Siglec-8 Antibody, Depletes Tissue Eosinophils and Improves Dysphagia Symptoms in Patients with Eosinophilic Esophagitis

2020 · Ikuo Hirano, Kathryn Peterson, et al. · Journal of Allergy and Clinical Immunology · 9

932 Histologic and Symptomatic Improvement Across Multiple Forms of Eosinophilic Gastrointestinal Diseases in Enigma, a Randomized, Double-blind, Placebo-controlled Trial of Antolimab (ak002)

2020 · Evan S. Dellon, Kathryn A. Peterson, et al. · Gastroenterology · 3

539 Long-term Treatment of Patients With Eosinophilic Gastritis And/or Eosinophilic Duodenitis With Lirentelimab, a Monoclonal Antibody Against Siglec-8

2021 · Kathryn A. Peterson, Mirna Chehade, et al. · Gastroenterology · 1

1247 Development of a Patient Reported Outcome (PRO) Questionnaire to Assess the Symptoms of Eosinophilic Gastritis and Gastroenteritis (EG/EGE-SQ©)

2019 · Ikuo Hirano, Evan S. Dellon, et al. · The American Journal of Gastroenterology · 1

S1421 Safety and Efficacy of Long-Term Treatment With Lirentelimab, A Monoclonal Antibody Against Siglec-8, in Patients With Eosinophilic Gastritis and/or Duodenitis

2021 · Joseph A. Murray, Kathryn Peterson, et al. · The American Journal of Gastroenterology

621 Pl02.05 Long-term Treatment of Patients With Eosinophilic Gastritis And/or Eosinophilic Duodenitis With Lirentelimab, a Monoclonal Antibody Against Siglec-8

2021 · Kathryn Peterson, Mirna Chehade, et al. · Diseases of the Esophagus

228 Interim Results of an Open-label Extension Study of Antolimab, an Anti-siglec-8 Antibody, for the Treatment of Patients With Eosinophilic Gastritis And/or Eosinophilic Enteritis

2020 · Kathryn A. Peterson, Joseph A. Murray, et al. · Gastroenterology

1244 Symptomatic Patients Suspected of Eosinophilic Gastritis and/or Enteritis Have Elevated Mucosal Mast Cell Counts Without Eosinophilia: A New Diagnostic Entity?

2019 · Joseph A. Murray, Evan S. Dellon, et al. · The American Journal of Gastroenterology

Works count: 9

Citation count: 282

H-index: 3

I10-index: 1